COVID-19 诊断市场规模、份额和成长分析（按产品、样本类型、测试类型、模式、最终用途和地区）- 2025-2032 年产业预测

2023 年 COVID-19 诊断市场规模价值 320.3 亿美元，预计将从 2024 年的 385.0 亿美元增长到 2032 年的 1677.6 亿美元，预计在预测期内（2025-2032 年）的复合年增长率为 20.2%。

2019 年 12 月，新冠肺炎疫情在中国武汉爆发，已造成全球超过 60 亿人死亡，对全球健康经济造成严重影响。该病毒的迅速传播导致世界卫生组织于 2020 年 3 月宣布为大流行病。医疗保健系统不堪重负，迫切需要在诊断和治疗方法取得进展。同时，封锁措施加剧了经济困难，失业率和通货膨胀上升导致全球GDP下降。研究工作集中在 205 种潜在治疗方法和 124 种疫苗上，特别是免疫疗法、抗病毒药物和细胞疗法。重点研究领域包括抗体开发和基于 RNA 的疫苗，凸显了对病毒的全面资料的需求，以製定有效的解决方案并确保公共卫生的復原力。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

COVID-19 诊断市场规模（按产品和复合年增长率） (2025-2032)

• 市场概况
• 装置
• 试剂和套件
• 服务

COVID-19 诊断市场规模（按样本类型和复合年增长率）（2025-2032 年）

• 市场概况
• 鼻咽拭子（NP）
• 口咽拭子
• 鼻拭子
• 血
• 其他的

COVID-19 诊断市场规模（按检测类型和复合年增长率） (2025-2032)

• 市场概况
• 分子（PCR）检测
• 抗原检测
• 抗体（血清学）检测
• 其他的

COVID-19 诊断市场规模（按模式和复合年增长率）（2025-2032 年）

• 市场概况
• 照护现场(PoC)
• 非照护现场(Non-PoC)

COVID-19 诊断市场规模（依最终用途和复合年增长率） (2025-2032)

• 市场概况
• 研究所
• 医院
• 诊断中心和诊所
• 其他的

COVID-19 诊断市场规模（按地区）及复合年增长率（2025-2032 年）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Thermo Fisher Scientific（United States）
• Hologic, Inc.（United States）
• QuidelOrtho Corporation（United States）
• QIAGEN NV（Netherlands）
• bioMerieux（France）
• Laboratory Corporation of America Holdings（Labcorp）（United States）
• Abbott Laboratories（United States）
• F. Hoffmann-La Roche AG（Switzerland）
• Siemens Healthineers AG（Germany）
• Becton, Dickinson and Company（BD）（United States）
• PerkinElmer, Inc.（United States）
• Danaher Corporation（United States）
• Bio-Rad Laboratories, Inc.（United States）
• OraSure Technologies, Inc.（United States）
• Luminex Corporation（United States）
• Seegene Inc.（South Korea）
• Tecan Group Ltd.（Switzerland）

结论和建议

COVID-19 Diagnostics Market size was valued at USD 32.03 billion in 2023 and is poised to grow from USD 38.5 billion in 2024 to USD 167.76 billion by 2032, growing at a CAGR of 20.2% during the forecast period (2025-2032).

The COVID-19 pandemic has profoundly affected global health and economies, originating in Wuhan, China, in December 2019 and subsequently leading to over 6 billion deaths worldwide. The rapid spread of the virus prompted the World Health Organization to declare it a pandemic in March 2020. Health systems are overwhelmed, necessitating urgent advancements in diagnosis and treatment options. Concurrently, lockdown measures have exacerbated economic difficulties, with rising unemployment and inflation contributing to global GDP decline. Research efforts are focused on 205 potential therapies and 124 vaccines, particularly in immunotherapy, antivirals, and cell-based treatments. Key areas of investigation include antibody development and RNA-based vaccines, highlighting the critical need for comprehensive data on the virus to inform effective solutions and ensure public health resilience.

Top-down and bottom-up approaches were used to estimate and validate the size of the Covid-19 Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Covid-19 Diagnostics Market Segments Analysis

Global COVID-19 Diagnostics Market is segmented by Product, Sample Type, Test Type, Mode, End-use and region. Based on Product, the market is segmented into Instruments, Reagents & Kits and Services. Based on Sample Type, the market is segmented into Nasopharyngeal (NP)swabs, Oropharyngeal (OP) swabs, Nasal swabs, Blood and Others. Based on Test Type, the market is segmented into Molecular (PCR) Testing, Antigen-based Testing, Antibody (Serology) Testing and Others. Based on Mode, the market is segmented into Point-of-Care (PoC) and Non-Point-of-Care (Non-PoC). Based on End-use, the market is segmented into Laboratories, Hospitals, Diagnostic Centers and Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Covid-19 Diagnostics Market

The COVID-19 diagnostics market has experienced significant growth due to the global response to the pandemic, as governments implemented lockdowns and invested heavily in healthcare and life sciences. This support catalyzed the rapid development of diagnostic tests and treatments for the virus. Furthermore, the FDA introduced an emergency use authorization (EUA) pathway, allowing for the swift approval of various therapies aimed at combatting COVID-19. Consequently, numerous pharmaceutical, biotechnology, and biopharmaceutical companies received EUA approvals, facilitating ongoing clinical studies and bolstering innovation in diagnostics. These concerted efforts have been pivotal in addressing the health crisis and enhancing diagnostic capabilities worldwide.

Restraints in the Covid-19 Diagnostics Market

One significant obstacle hindering the progress of the Covid-19 diagnostics market is the insufficient information regarding the novel coronavirus, particularly its biological and genetic characteristics, as well as the longevity of immunity in individuals who have recovered from the virus. This knowledge is crucial for the creation of safe and effective diagnostic solutions. Furthermore, as the industry moves forward, it must navigate challenges related to production capacity and distribution logistics. Consequently, alongside ongoing vaccine development, manufacturers are prioritizing the enhancement of their production capabilities to address these emerging challenges effectively.

Market Trends of the Covid-19 Diagnostics Market

The Covid-19 diagnostics market has exhibited a significant shift towards in vitro diagnostics, with a strong emphasis on developing highly reliable and cost-effective testing solutions. As of July 2021, over 500 point-of-care (POC) diagnostic tests were available, reflecting a growing trend towards rapid testing that delivers faster results to facilitate timely decision-making. This surge in innovation is driven by collaboration between private companies and government initiatives to enhance public health response capabilities. The focus on improving test accuracy and accessibility underscores a market trajectory toward more sophisticated diagnostic technologies, which are anticipated to shape ongoing pandemic management and preparedness for future outbreaks.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global COVID-19 Diagnostics Market Size by Product & Service & CAGR (2025-2032)

• Market Overview
• Instruments
• Reagents & Kits
• Services

Global COVID-19 Diagnostics Market Size by Sample Type & CAGR (2025-2032)

• Market Overview
• Nasopharyngeal (NP) swabs
• Oropharyngeal (OP) swabs
• Nasal swabs
• Blood
• Others

Global COVID-19 Diagnostics Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• Molecular (PCR) Testing
• Antigen-based Testing
• Antibody (Serology) Testing
• Others

Global COVID-19 Diagnostics Market Size by Mode & CAGR (2025-2032)

• Market Overview
• Point-of-Care (PoC)
• Non-Point-of-Care (Non-PoC)

Global COVID-19 Diagnostics Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Laboratories
• Hospitals
• Diagnostic Centers and Clinics
• Others

Global COVID-19 Diagnostics Market Size & CAGR (2025-2032)

• North America (Product & Service, Sample Type, Test Type, Mode, End-use)
  • US
  • Canada
• Europe (Product & Service, Sample Type, Test Type, Mode, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Sample Type, Test Type, Mode, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Sample Type, Test Type, Mode, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Sample Type, Test Type, Mode, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings (Labcorp) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OraSure Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seegene Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecan Group Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations